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Abstract
Lipofilling has recently gained popularity as a tool in primary treatment of breast cancer, and its association with two-stage
implant breast reconstruction is considered as standard treatment in many centers. However, no data are available about the long-
term results of the association of lipofilling in combination with expander-implant reconstruction. A retrospective analysis was
conducted on patients treated between January 2010 and December 2014. Two groups were compared. Group 1 had a standard
expander-implant two-stage reconstruction. Group 2 underwent hybrid breast reconstruction (HBR). Patient characteristics,
hospitalization, outcomes, reoperation details, outpatient visits, and evaluation questionnaires were taken into consideration.
Intergroup comparison was performed using Wilcoxon Mann-WhitneyU test and Pearson’s chi-square test or Fisher’s exact test
for categorical variables. Two hundred fourteen patients were evaluated: 130 patients in group 1 and 84 patients in group 2.
Group 2 showed significant benefits over group 1 in terms of capsular contracture rate, breast pain, and displacement/rotation of
the implant (p = 0.005). The HBR protocol is associated with lower rate of capsular contracture, less breast pain at long follow-up
times, and lower overall rates of revision surgery compared to standard expander-implant reconstruction. A specific cost analysis
will help further clarify the advantages of this protocol over a standard procedure.
Level of Evidence: Level III, risk/prognostic, therapeutic study.
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Introduction
Lipofilling is one of the most investigated topics in Plastic
Surgery in recent decades, although the use of adipose tissue
for reconstruction purposes can be traced back to studies pub-
lished a century ago. Neuber and Guthrie, respectively, first
described the use of adipose tissue to restore body shape after
tuberculosis and to correct depressed areas after mastoid sur-
gery [1, 2]. Thanks to the introduction of liposuction described
by Fisher in 1974, 20 years later, the term lipofilling is now in
common use [3]; this is also due to the pivotal work by Roddi
et al. on correction of progressive hemifacial atrophy [4].
Since then, lipofilling has gained widespread popularity, and
its use in breast surgery has become a standard procedure [5].
Fat grafting has been proposed as a tool to improve the out-
come for capsular contracture after breast implant reconstruc-
tion [6–9]. Even in breast implant augmentation, lipofilling
now has a well-recognized role [10, 11]. A large number of
studies have investigated the technique of fat grafting, its safe-
ty in breast surgery, the variations offered by the different
types of harvesting techniques, optimal donor site, device
employed, elaboration of adipose tissue, recipient site prepa-
ration, and timing of surgery [12–20].Many reviews are avail-
able comparing dozens of studies, analyzing every step of the
lipofilling procedure, in order to find a standard method to
ensure the best graft-taking rate [21–23].
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Fat grafting leads to improved outcomes in breast implant
surgery [24, 25]. Its use on secondary cases can show a ben-
eficial effect after the complication has been assessed in detail,
and the introduction of further surgical steps (lipofilling) at the
time of expansion can reduce unfavorable outcomes.
The aim of our study is to evaluate long-term results of a
“hybrid breast reconstruction” (HBR) protocol [26], wherein
fat grafting is performed during the course of the expander/
implant reconstruction. The main object of the study is to
determine the rate of capsular contracture. Secondary
outcomes were analysis of postoperative complications, re-
operations performed or refused by the patient, and the assess-
ment of the esthetic result.
Materials and methods
A retrospective study was conducted taking into consideration
all surgical breast reconstructive procedures with two-stage
expander/implant reconstruction. The population was divided
into two cohorts. Group 1 includes patients who underwent
expander/implant standard reconstruction and represents the
control group. Group 2 includes patients who underwent the
HBR protocol. Criteria for exclusion were chronic liver dis-
ease, coagulopathies, and/or anticoagulant therapy, patients
who underwent mammary reconstruction after trauma or con-
genital disease, and patients lost to follow-up.
All procedures performed were in accordance with the eth-
ical standards of the Institutional Committee and with the
1964 Helsinki declaration and its later amendments. Written
informed consent was obtained from all patients. This study is
in line with the STROCSS criteria [27].
Patients and methods
A retrospective chart review was performed for 84 consecu-
tive postmastectomy patients who underwent secondary
breast reconstruction from January 2010 to December
Fig. 1 Thickness of mastectomy flaps was evaluated with pinch test and
ultrasound in five different areas of the breast: the first template is over the
central quadrant (nipple-areola complex area) and other four are circum-
ferential. The dimension of each template is 4 × 4 cm
Fig. 2 a–d Preoperative pictures
of a 42-year-old patient who
underwent nipple sparing mas-
tectomy and expander immediate
reconstruction. e Ultrasound
evaluation of the subcutaneous
tissue with 1.07 cm measurement.
f–i Postoperative result after
24 months from the second sur-
gical step of expander/implant
exchange procedure. The patient
had one lipofilling session during
the latter surgery
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2014 at our institute. Our study population (group 2) was aged
between 35 and 65 years old, who underwent the same surgi-
cal procedure (unilateral mastectomy, immediate reconstruc-
tion with a tissue expander, and replacement with definitive
implant), with similar follow-up and the same type of thera-
peutic approach in terms of complementary therapies.
After unilateral mastectomy and immediate reconstruction
with an expander, these patients were submitted to one to three
serial deflation-lipofilling procedures. Positioning of a defini-
tive prosthesis was performed during the last lipofilling
session.
Table1 Pati ent demographics,
breast cancer histology, frequency
of relapses, metastasis and second
cancer, comorbidities, breast
implants employed in
reconstruction, procedures for
symmetrization of the
contralateral breast
Group 1 Group 2
Patient age (average) (years) 57 55
Follow-up (average) (months) 36.15 32.91
No.
patients
% group 1 No.
patients
% group 2 p
group 1 group 2
Breast cancer histology
- CaDI 84 65.12% 59 71.95%
- DCIS 11 8.53% 5 6.10%
- DCIN 11 8.53% 5 6.10% 0.475
- CaLI 10 7.75% 9 10.98%
- CaDLI 9 6.98% 3 3.66%
- Other 4 3.10% 1 1.22%
Relapses/metastasis 8 6.15% 3 3.57% 0.403
Second cancer 3 2.31% 4 4.76% 0.324
Radiotherapy 16 12.31% 22 26.19% 0.009*
Chemiotherapy 78 60% 53 63.10% 0.650
Ormonotherapy 101 77.69% 68 80.95% 0.567
Comorbidities
Smoker 30 23.08% 10 11.09% 0.040*
Diabetes 3 2.31% 5 5.95% 0.169
Rheumatic disease 6 4.62% 5 6.02% 0.650
Obesity 31 23.85% 20 24.10% 0.966
Other diseases 72 55.38% 44 52.38% 0.666
Type of surgical procedure
Simplex mastectomy 107 82.31% 65 77.38 0.844
Skin sparing mastectomy 13 10% 11 13.10%
Nipple sparing mastectomy 9 6.92% 7 8.33%
Skin reducing mastectomy 1 0.77% 1 1.19%
Delayed reconstruction 18 13.85% 5 5.95% 0.068
Contralateral breast
symmetrization
10 7.75% 4 4.88% 0.457
Prophylactic mastectomy 2 1.54% 2 2.38% 0.656
Type of prosthesis
Allergan 4 3.08% 27 32.14% < 0.0001
Mentor 126 96.92% 52 61.90%
Polytech 0 0 5 5.95%
Procedures for symmetrisation of the contralateral breast
Reductive mastoplasty 14 16.28% 9 17.31% 0.654
Augmentation mammoplasty 30 34.88% 21 40.38%
Mastopexy 40 46.51% 20 38.46%
Autologous reconstruction 2 2.33% 1 1.92%
Lipofilling 0 0 1 1.92%
*p < 0.05 was accepted as the level of statistical significance
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Patients were assessed for the thickness of mastectomy
flaps and the presence of radiotherapy. For mastectomy skin
flap thickness < 0.5 cm and/or those subjected to radiotherapy,
patients were submitted to two lipofilling sessions before re-
placement of the expander. Smoking habit was not taken into
account for patient selection.
For this study, a group of 130 subjects who underwent the
standard expander/implant reconstruction was selected as the
control population (group 1).
All patients underwent surgery by the senior author of this
study (P.C.P). Patients were examined on postoperative days
3, 7, and 14, and follow-up visits were scheduled at 1 month
and every 6 months postoperatively. Clinical evaluation of the
reconstruction and patient satisfaction were recorded.
Assessment of capsular contracture was based on Baker’s
modified classification [28].
Preoperative planning and HBR protocol
The first surgical step was the same for all patients as they
underwent mastectomy and reconstruction with a breast tissue
expander. Mastectomy skin flap thickness was determined at
3 months postoperative at the end of the outpatient expansion
procedures by a pinch test (by a skinfold caliper) and ultra-
sound [29]. Five regions of the breast were identified with a
template, and measurements were recorded in the same area in
all participants with both measurement devices (see Fig. 1).
Pinch caliper measurements In the middle box of each tem-
plate, a skin caliper (Gima, Gessate, Italy) was used to mea-
sure subcutaneous fat thickness. One measurement for each
was taken in each middle box, for a total of 5 measurements.
The clinician (S.C.) taking the skinfold caliper measurement
was right-hand dominant, so with her left thumb and forefin-
ger she lifted the skin away from the muscle and pinched it
together. With her right hand, she placed the jaws of the
skinfold caliper inferior to the pinch and completely released
her thumb from the handle. The reading was recorded after the
first rapid fall on the dial.
The fat thickness recorded by the skinfold caliper was di-
vided in half to represent the subcutaneous fat layer over the
muscle.
Ultrasound imaging Ultrasound imaging (GE Heathcare
Logiq F8, Waukesha, WI) was used to measure subcutaneous
fat thickness in each middle box. An 8-MHz linear array was
used while capturing the image in B-mode. Ultrasound gel
was applied liberally to the center of the template before plac-
ing the transducer on the skin. After a clear image was iden-
tified, the image was saved.
Fig. 3 Distribution of Wilcoxon scores for breast prosthesis volume (a), quantity of fat infiltration (b), and duration of intervention (replacement of the
breast tissue expander with permanent implant, in minutes) (c)
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The images were labeled with the participant number and
site (upper, central, left, right, below) of measurement. On a
subsequent day, the clinician (S.C.) who obtained the images
opened the saved images and measured subcutaneous fat
thickness using the measurement tool.
All the patients who were randomly selected to have HBR
protocol accepted it, and signed informed consent was obtain-
ed from all.
Depending on the skin thickness and previous radiothera-
py, an average of 1 to 3 deflation-lipofilling sessions were
programmed (see Fig. 2a–i). If a single lipofilling procedure
was necessary, it was performed at the time of expander/
implant exchange procedure. If multiple deflation-lipofilling
sessions were scheduled, they were performed after final fill-
ing of the tissue expander. The fat was positioned at the level
of the mastectomy flap, between skin and peri-prosthetic cap-
sule. Deflation was conducted to be 10 cc superior to the total
amount of fat injected.
If we noticed the skin over the breast area was too stretched
after the fat grafting session, we would remove a greater quan-
tity of saline solution from the breast expander. Deflation-
lipofilling sessions were scheduled every 3 months.
In all patients, anatomical textured silicone gel implants
were placed in the subpectoral pocket. All patients received
perioperative antibiotic prophylaxis (cephazolin 2 g, intrave-
nous injection, 30 min before the beginning of surgery).
Questionnaire
Patients were asked to fill in the postoperative BREAST-Q
reconstruction questionnaire [30–32] to evaluate the out-
comes. The BREAST-Q reconstruction module has the fol-
lowing scales: satisfaction with breasts, satisfaction with im-
plants, psychosocial well-being, sexual well-being, physical
well-being. We administered the questionnaire electronically
2 years after surgery.
We compared patient questionnaire scores (group 1 vs
group 2) to determine if there was a significant improvement
in esthetic outcomes between the groups.
Statistical analysis
Intergroup comparison was performed using aMann-Whitney
U test and Pearson’s chi-square test or Fisher’s exact test for
categorical variables. A p < 0.05 was accepted as the level of
statistical significance.
The chi-squared test is used to compare the distribution of
the Breast-Q items in group 1 and 2. p < 0.01 was accepted as
the level of statistical significance.
Data were analyzed using SPSS version 22.0 (IBM statis-
tics for Windows version 22, IBM Corporation, Armonk, NY,
USA). Ta
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Results
Patient demographics are reported in Table 1. The mean age of
patients was 57 years for group 1 and 55 years for group 2.
Patient follow-up was considered in months, with an average
of 36.15 for group 1 (range 12–60 months) and 32.91 for
group 2 (range 12–50 months). The clinical history of these
patients included at least two operations. The first was mas-
tectomy; 191 patients (89.25%) underwent immediate recon-
struction with a tissue expander. The second step in-
cluded expander replacement by definitive implant; one
to three deflation-lipofilling sessions were scheduled
during this second surgical phase for patients in group
2. With regard to delayed breast reconstruction, it was
more frequent in group 1 (14%) compared to group 2
(6%). Radiotherapy was administrated to 16 (12.3%)
patients in group 1 and 22 (26.19%) patients in group
2.
Tissue expanders were left in place for a mean of 15 weeks
(range 13–19), and replacement with the final prosthesis was
performed after a mean of 19 weeks (range 17–25). The mean
volume of the definitive prosthesis was 438 cc (range 150–
800 cc): although there were no statistically significant differ-
ences between groups (p > 0.05), larger volume prostheses
were used in group 1 (Fig. 3a).
All patients in group 2 had at least one lipofilling session at
the time of removal of the expander. Moreover, nine patients
had a total of two lipofilling sessions and six patients had a
total of three lipofilling sessions.
Thirty-four patients (26%) from group 1 underwent
lipofilling as a secondary procedure. There was one session
for 29 patients, two sessions for four patients, and three ses-
sions in one patient.
The average quantity of adipose tissue infiltrated for both
groups was 88.27 cc (85.26 cc for group 1 and 89.5 cc for
group 2).
There was a significant difference between groups
(p > 0.05) regarding the total amount of adipose tissue infil-
trated: there was more fat infiltration in group 2 (Fig. 3b).
Postoperative complications (Table 2) included 6 hemato-
mas for group 1 (p = 0.045), 7 seromas (5 for group 1 and 2 for
group 2), 5 implant infections (4 for group 1 and 1 for group
2), and one case of breast prosthesis rupture (group 1). There
were no significant differences between groups regarding
asymmetry (p > 0.05). Incidence of capsular contracture in
two groups was the most important endpoint of our study
for which a significant difference between groups was found
(p = 0.004). Twenty-eight patients developed capsular con-
tracture in group 1 (21.53%) compared to 6 in group 2
(7.14%).
Thirty-eight patients in group 1 (29.24%) and 9 (10.72%)
patients in group 2 presented displacement/rotation of the im-
plant (p = 0.001).
The difference in the onset of breast pain between groups
was statistically significant (p = 0.013): it involved 18 patients
in group 1 and 3 patients in group 2.
Outcomes were similar regarding the reoperation rate: as
shown in Table 2, there were no significant differences be-
tween groups regarding the number of prosthesis
replacements (p = 0.127) and prosthesis removals (p = 0.253).
For group 2, we considered fat grafting procedures not
included in HBR protocol, but which were conducted as sec-
ondary procedures. We did not observe any significant differ-
ence between the experimental and control group for second-
ary fat grafting procedures (p = 0.431). Refusal of reoperation
between groups was statistically significant.
To understand the difference in costs regarding the recon-
structive protocol in groups 1 and 2, we assessed surgical time
in the operating room, number of hospitalization days, number
of interventions required for each patient, and number of out-
patient department visits.
With regard to surgical time, the hybrid breast reconstruc-
tion was longer than the surgical procedure in the control
population (p < 0.0001). This indicates that HBR was more
expensive compared with the replacement of the breast ex-
pander with a permanent implant standard procedure (Fig. 3c).
However, there were no significant differences between
groups regarding the number of definitive prostheses and
breast tissue expanders used, number of admissions to
Table 3 Costs of breast reconstruction procedures for each group
Admission
in
hospital (no.)
Operation
(no.)
Hospitalization
days (no.)*
Hospitalization
days (no.)**
Total days in the
hospital (no.)
Outpatient
department
visits (no.)
Group 1 1.44 1.47 3.94 1.67 4.85 6,9
Group 2 2 2 3 2 5.07 6
p 0.097 0.170 0.009 0.252 0.562 0.449
*Days in the hospital for the first operation (mastectomy and immediate reconstruction with an expander)
**Days in the hospital for the second operation (the replacement of the expander with permanent implant ± lipofilling)
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Table 4 BREAST-Q postoperative module in patients following expander/implant standard 456 reconstruction (group 1) or HBR protocol (group 2)
Question Post (group 1) Post (group 2) p (2 years)
No. (%) 87 64 –
Satisfaction with breasts
How you look in the mirror clothed? 55 (63) 46 (71) 0.34
The shape of your reconstructed breast(s) when you are wearing a bra? 63 (72) 50 (78) 0.54
How normal you feel in your clothes? 67 (77) 52 (81) 0.66
The size of your reconstructed breast(s)? 74 (85) 57 (89) 0.63
Being able to wear clothing that is more fitted? 64 (74) 51 (80) 0.49
How your breasts are lined up in relation to each other? 63 (72) 58 (90) 0.01*
How comfortably your bras fit? 67 (77) 55 (86) 0.24
The softness of your reconstructed breast(s)? 46 (53) 54 (84) 0.0001*
How equal in size your breasts are to each other? 70 (80) 58 (90) 0.13
How natural your reconstructed breast(s) looks? 47 (64) 45 (70) 0.04
How naturally your reconstructed breast(s) sits/hangs? 44 (51) 56 (88) 0.0001*
How your reconstructed breast(s) feels to touch? 48 (55) 57 (89) 0.0001*
How much your reconstructed breast(s) feel like a natural part of your body? 34 (39) 43 (68) 0.0012*
How closely matched (similar) your breasts are to each other? 47 (54) 39 (60) 0.72
How you look in the mirror unclothed? 39 (44) 35 (54) 0.30
Satisfaction with implants
The amount of rippling (wrinkling) of your implant(s) that you can see? 51 (59) 57 (89) 0.0001*
The amount of rippling (wrinkling) of your implant(s) that you can feel? 47 (54) 58 (90) 0.0001*
Psychosocial well-being
Confident in a social setting? 71 (82) 54 (84) 0.82
Emotionally able to do the things that you want to do? 67 (77) 48 (75) 0.77
Emotionally healthy? 72 (82) 54 (84) 0.79
Of equal worth to other women? 70 (80) 49 (77) 0.56
Self-confident? 75 (86) 53 (83) 0.56
Feminine in your clothes? 78 (89) 58 (90) 0.84
Accepting of your body? 77 (88) 58 (90) 0.67
Normal? 77 (88) 55 (86) 0.63
Like other women? 78 (89) 58 (90) 0.84
Attractive? 63 (72) 43 (68) 0.48
Sexual well-being
Sexually attractive in your clothes? 64 (74) 46 (71) 0.81
Comfortable/at ease during sexual activity? 55 (63) 39 (60) 0.77
Confident sexually? 63 (72) 45 (70) 0.77
Satisfied with your sex-life? 64 (73) 48 (75) 0.84
Confident sexually about how your breast area looks when unclothed? 47 (54) 36 (56) 0.78
Sexually attractive when unclothed? 39 (44) 36 (55) 0.16
Physical well-being
Neck pain? 34 (39) 23 (35) 0.69
Upper back pain? 33 (38) 23 (35) 0.80
Shoulder pain? 33 (38) 24 (37) 0.95
Arm pain? 25 (29) 17 (27) 0.76
Rib pain? 40 (45) 21 (32) 0.10
Pain in the muscles of your chest? 57 (65) 21 (32) 0.0001*
Difficulty lifting or moving your arms? 25 (29) 17 (27) 0.76
Difficulty sleeping because of discomfort in your breast area? 39 (44) 21 (32) 0.13
Tightness in your breast area? 51 (59) 23 (35) 0.005*
Pulling in your breast area? 50 (57) 23 (35) 0.008*
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hospital, number of interventions required for each patient,
number of hospitalization days, or number of outpatient de-
partment visits (Table 3).
Eighty-six patients of group 1 and sixty-four of group 2
completed BREAST-Q surveys, with a response rate of 66%
for group 1 and 78% for group 2.
The answers of the patients to the BREAST-Q and the
statistical analysis are shown in Table 4 and Fig. 4a, b. After
further analysis of the questionnaire, we observed that patients
in group 2 obtained significantly better postoperative results
than patients from group 1 (control) regarding the following
items: the reconstructed breast softness, symmetry (breasts of
equal size relative to the other), reconstructed breast look and
touch, amount of implant rippling perceived by the patients,
and physical well-being about chest and upper body.
Discussion
A number of studies have been carried out on the introduction
of lipofilling as a preliminary step in breast reconstruction for
patients undergoing mastectomy and radiotherapy [33, 34].
Several authors have proposed the use of lipofilling on ex-
panders, limiting this indication to patients who received post-
mastectomy radiotherapy (PMRT) [35]. In 2008, Sarfati et al.
published an analysis of 28 patients who underwent multiple
lipofilling sessions to prepare the thoracic region for breast
implant reconstruction [36]. Panettiere et al., in 2009, were
the first to propose fat grafting as a surgical tool for improving
outcomes of breast implant reconstruction after radiotherapy
in a case-control study. Improved esthetic and functional result
were reported, together with a reduced complication rate, in
the study group [36]. Between 2010 and 2012, Salgarello et al.
published their LIPOBED protocol [34, 37].
In 2010, Serra-Renom et al. [38] introduced two fat
grafting sessions during two-stage breast implant reconstruc-
tion. No statistical analysis was conducted, but they reported a
lower rate of capsular contraction.
In 2013, Ribuffo et al. published the Cagliari University
Hospital (CUH) protocol for breast reconstruction after
PMRT. This was a case control study with no report of com-
plications in the study group [35, 39].
The concept of lipofilling has evolved as a primary
tool in breast reconstruction. Deflation-lipofilling ses-
sions are conducted to prevent complications during
the reconstructive step, limiting the onset of postopera-
tive complications. As other authors promote the use of
polyurethane implants as a first step in breast recon-
struction to reduce complication rates [40, 41] and not
only as a rescue tool after a failure, in the same way,
the present study investigated the beneficial effect of fat
grafting as a part of the standard two-stage breast im-
plant reconstruction for all postmastectomy patients in
order to reduce overall capsular contracture and improve
the esthetic result.
This is the first report of 84 patients, a case-control
study, with a mean follow-up time of 34.87 months.
Statistical analysis showed that fat grafting may have a
role in reducing the capsular contracture rate. One to
three more surgeries per patient should be cost-
effective for a Plastic Surgery Department. Operative
time at the moment of expander/implant exchange has
been reported to be significantly longer for HBR.
However, the number of hospitalizations, surgical proce-
dures, and outpatient sessions did not show any signif-
icant differences.
The beneficial effect of deflation-lipofilling procedures,
despite adjunctive costs, was evaluated by Sommeling et al.
and Stillaert et al. [42, 43]. The latter study included the re-
moval of the expander at the end of the programmed recon-
struction, without any implant positioning, in order to guaran-
tee a total autologous reconstruction. The same conclusion
was reached by the study by Fabiocchi et al. [44].
The study by Sommeling et al. was detailed and endoscop-
ic imaging was used to show the capsular vascular plexus,
which is related to increased survival of adipose tissue.
However, that study involved a limited number of patients,
without a control group and with 9 to 29 months of follow-up.
Nava et al. reported on a large series of 350 patients treated
with lipofilling and implants. He reported detailed algorithms
Table 4 (continued)
Question Post (group 1) Post (group 2) p (2 years)
Nagging feeling in your breast area? 50 (57) 23 (35) 0.008*
Tenderness in your breast area? 39 (44) 30 (47) 0.80
Sharp pains in your breast area? 57 (65) 20 (31) 0.0001*
Shooting pains in your breast area? 63 (72) 29 (46) 0.0007*
Aching feeling in your breast area? 62 (71) 23 (35) 0.0001*
Throbbing feeling in your breast area? 64 (73) 26 (41) 0.0001*
Raw score ≥ 4
*p < 0.01 was accepted as the level of statistical significance
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for the surgical pathway to follow regarding the patient BMI.
Although in that study there is no study description, statistical
analysis, or detailed results [45].
Since Rigotti’s work on the effect of adipose tissue on
radiated breast [46], many attempts have been made to further
confirm the advantages of fat grafting procedures. Indeed, the
Fig. 4 a, bBox plot of estimated correlation values by Breast-Q domains.
Within each box, horizontal middle lines denote median values; boxes
extend from the 25th to the 75th percentile of each group’s distribution of
values; vertical extending lines denote adjacent values (i.e., the most
extreme values within 1.5 interquartile range of the 25th and 75th per-
centile of each group)
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most recent studies on combined implant/lipofilling approach
continue to show satisfactory results.
The explanation for the lower rate of capsular contracture
provided by fat grafting has not yet been answered. Won-Serk
et al. underlined how adipose stem cells lead to an increase in
fibroblasts and their stimulation with increased collagen pro-
duction of type 1 and fibronectin. Their results showed a ben-
eficial effect of adipose stem cell treatment on wound healing
in mice and the absence of a significant number of inflamma-
tory cells in the dermis of wounds [47]. Reduction in the
number of cells with chronic inflammation cells may be one
of the factors contributing to the reduced capsular contracture
rate.
By using a validated survey tool (BREAST-Q), in this
study, we show that patient of group 2 were significantly more
satisfied with the appearance of their breast and showed an
improved psychosocial, sexual, and physical well-being than
patients exposed to prosthetic reconstruction alone.
As already reported by other authors [31, 48, 49], fat
grafting provides a significant analgesic effect in patients
who underwent an implant-based breast reconstruction.
The current study is not exempt from limitations and main-
ly represented by the relatively small size of the examined
sample, short follow-up, and clinical and radiological evalua-
tions that are highly physician-dependent, and its retrospective
design.
Conclusions
The HBR protocol is associated with a lower rate of capsular
contracture, less breast pain at long follow-up times, and a
lower overall rate of revision surgery compared to standard
expander-implant reconstruction. A specific cost analysis
could further clarify the advantages of this protocol vs. a stan-
dard procedure.
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